Arthritis & Rheumatism

Is metabolic syndrome a modifiable risk factor for gout?

In a study published in Arthritis & Rheumatology that included nearly 1.3 million men aged 20–39 years who participated in three serial health check-ups at two-year intervals, men with metabolic syndrome (MetS) and those ...

Medications

Medication apremilast leads to fat loss in people with psoriasis

For years, apremilast (brand name Otezla) has helped psoriasis patients achieve clearer skin and ease the symptoms of their psoriatic arthritis. Now, new data from researchers at the Perelman School of Medicine at the University ...

page 8 from 40